Cantor Fitzgerald, L. P. Amryt Pharma PLC Transaction History

Cantor Fitzgerald, L. P.

  • $1.04 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$6.8 - $8.01 $129 - $152
-19 Reduced 0.02%
81,966 $567,000
Q2 2022

Aug 15, 2022
SELL
$6.85 - $8.87 $137,000 - $177,399
-20,000 Reduced 19.61%
81,985 $573,000
Q1 2022

May 16, 2022
BUY
$6.3 - $10.86 $138,719 - $239,126
22,019 Added 27.54%
101,985 $843,000
Q4 2021

Feb 14, 2022
BUY
$9.44 - $12.24 $754,879 - $978,783
79,966 New
79,966 $864,000

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Cantor Fitzgerald, L. P. Portfolio

Follow Cantor Fitzgerald, L. P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

News

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email